Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Total Non-current Liabilities
All obligations due after more than one year.
Total Non-current Liabilities history
Currency unavailable · from the balance sheet
No Total Non-current Liabilities data reported for this period type.
Total Non-current Liabilities vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $906.33M USD | -1.3% | -8.5% | 43.1% | |
| Mar 2026 | $669.04M USD | +89.6% | +12.0% | 89.9% | |
| Mar 2026 | $4.4M USD | -32.2% | +166.5% | 2.7% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 330.36K SEK | — | — | 0.3% |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -1.3% | +12.0% | 22.9% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.